Genetic Insight Into AH Receptor-Mediated Promotion Of Hepatocarcinogenesis

AH 受体介导的肝癌发生的遗传学见解

基本信息

  • 批准号:
    7642788
  • 负责人:
  • 金额:
    $ 15.54万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-05-01 至 2014-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant) The objective of this project is to understand the mechanism of Ah receptor-mediated liver tumor promotion using the mouse as a model system. To accomplish this task, the investigators will attempt to unravel the mechanism by which a prototype chemical, 2,3,7,8-tetra-chlorodibenzo-p-dioxin ("dioxin"), acts as promoter of hepatocellular carcinoma in the two-stage model. The choice of dioxin is related to its biological potency and the large volume of genetic and pharmacological evidence that suggests its effects are mediated through a single ligand-activated transcription factor known as the Ah Receptor (AHR). Given the central nature of this signaling protein, efforts will be made to elucidate the molecular details of the dioxin-AHR pathway as it relates to liver tumor promotion. To this end, gene targeting will be used to manipulate various functional domains and expression patterns of the AHR, as well as its heterodimeric partner ARNT. The overall goal is to identify the signaling steps, transcriptional targets and cell types that are essential for dioxin-promoted hapatocarcinogenesis and receptor mediated hepatovascular development. To this end, the following specific aims are proposed. Specific Aim 1: Use conditional and null alleles to determine the cell types that participate in the promotional effects of dioxin. Specific Aim 2: Determine if the signal transduction of dioxin promotion is similar to AHR pathways that regulate xenobiotic metabolism and hepatovascular development. Specific Aim 3: Examine existing candidate genes for roles upstream of AHR-mediated tumor promotion. Specific Aim 4: Identify additional genes that are candidates for roles in AHR-mediated tumor promotion.
描述(由申请人提供)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gregory Dean Kennedy其他文献

Gregory Dean Kennedy的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gregory Dean Kennedy', 18)}}的其他基金

The Role of Aryl Hyrocarbon Receptor in Colon Tumorigenesis
芳基烃受体在结肠肿瘤发生中的作用
  • 批准号:
    9380375
  • 财政年份:
    2016
  • 资助金额:
    $ 15.54万
  • 项目类别:
The Role of Aryl Hydrocarbon Receptor in Colon Tumorigenesis
芳基烃受体在结肠肿瘤发生中的作用
  • 批准号:
    8776713
  • 财政年份:
    2013
  • 资助金额:
    $ 15.54万
  • 项目类别:
The Role of Aryl Hydrocarbon Receptor in Colon Tumorigenesis
芳基烃受体在结肠肿瘤发生中的作用
  • 批准号:
    8439001
  • 财政年份:
    2013
  • 资助金额:
    $ 15.54万
  • 项目类别:
The Role of Aryl Hydrocarbon Receptor in Colon Tumorigenesis
芳基烃受体在结肠肿瘤发生中的作用
  • 批准号:
    8974832
  • 财政年份:
    2013
  • 资助金额:
    $ 15.54万
  • 项目类别:
The Role of Aryl Hydrocarbon Receptor in Colon Tumorigenesis
芳基烃受体在结肠肿瘤发生中的作用
  • 批准号:
    8640944
  • 财政年份:
    2013
  • 资助金额:
    $ 15.54万
  • 项目类别:
The role of the aryl hydrocarbon receptor in colon tumorigenesis
芳烃受体在结肠肿瘤发生中的作用
  • 批准号:
    8447129
  • 财政年份:
    2012
  • 资助金额:
    $ 15.54万
  • 项目类别:
Genetic Insight Into AH Receptor-Mediated Promotion Of Hepatocarcinogenesis
AH 受体介导的肝癌发生的遗传学见解
  • 批准号:
    8462606
  • 财政年份:
    2009
  • 资助金额:
    $ 15.54万
  • 项目类别:
Genetic Insight Into AH Receptor-Mediated Promotion Of Hepatocarcinogenesis
AH 受体介导的肝癌发生的遗传学见解
  • 批准号:
    7822829
  • 财政年份:
    2009
  • 资助金额:
    $ 15.54万
  • 项目类别:
Genetic Insight Into AH Receptor-Mediated Promotion Of Hepatocarcinogenesis
AH 受体介导的肝癌发生的遗传学见解
  • 批准号:
    8068016
  • 财政年份:
    2009
  • 资助金额:
    $ 15.54万
  • 项目类别:
Genetic Insight Into AH Receptor-Mediated Promotion Of Hepatocarcinogenesis
AH 受体介导的肝癌发生的遗传学见解
  • 批准号:
    8265306
  • 财政年份:
    2009
  • 资助金额:
    $ 15.54万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 15.54万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 15.54万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 15.54万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 15.54万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 15.54万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 15.54万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 15.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 15.54万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 15.54万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 15.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了